Fully agree. It needs to be a capital light setup with expanding use cases for pain management. I definitely think the product can stand on its own feet, the question is can they generate scale through these use cases which I believe is very possible. Slim down the core business and focus on marketing and influencing the right levels for mass distribution and get some good partners
Fully agree. It needs to be a capital light setup with expanding...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.69M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 46.0¢ | 44.0¢ | $10.2K | 22.82K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 41949 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 13548 | 3 |
View Market Depth
| Last trade - 15.47pm 04/10/2024 (20 minute delay) ? |
| MVP (ASX) Chart |